NPSR1; | |
MAPKAPK5; PRKCD; MAPKAPK2; | |
NR1H4; | |
GMNN; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Protein Kinase | MAPKAPK5 | MAP kinase-activated protein kinase 5 | Q8IW41 | CHEMBL3094 |
Protein Kinase | PRKCD | Protein kinase C delta | Q05655 | CHEMBL2996 |
Protein Kinase | MAPKAPK2 | MAP kinase-activated protein kinase 2 | P49137 | CHEMBL2208 |
Unclassified | GMNN | Geminin | O75496 | CHEMBL1293278 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0009931; calcium-dependent protein serine/threonine kinase activity | 4.417E-06 | 5.770E-02 | MAPKAPK2, MAPKAPK5 |
BP | GO:0008152; metabolic process | GO:0018105; peptidyl-serine phosphorylation | 1.201E-05 | 8.495E-02 | MAPKAPK2, MAPKAPK5, PRKCD |
BP | GO:0009987; cellular process | GO:0090398; cellular senescence | 3.972E-05 | 8.649E-02 | MAPKAPK5, PRKCD |
BP | GO:0065007; biological regulation | GO:0032147; activation of protein kinase activity | 8.206E-05 | 1.289E-01 | MAPKAPK2, MAPKAPK5, PRKCD |
CC | GO:0043226; organelle | GO:0005654; nucleoplasm | 4.855E-04 | 1.788E-01 | GMNN, MAPKAPK2, MAPKAPK5, NR1H4, PRKCD |
MF | Unclassified; | GO:0004871; signal transducer activity | 8.023E-04 | 2.142E-01 | MAPKAPK2, MAPKAPK5, NPSR1, NR1H4 |
MF | GO:0003824; catalytic activity | GO:0004699; calcium-independent protein kinase C activity | 9.316E-04 | 2.142E-01 | PRKCD |
CC | GO:0044464; cell part | GO:0005737; cytoplasm | 2.269E-03 | 3.555E-01 | GMNN, MAPKAPK2, MAPKAPK5, NPSR1, PRKCD |
CC | GO:0044464; cell part | GO:0035578; azurophil granule lumen | 2.794E-02 | 1.000E+00 | PRKCD |
CC | GO:0044464; cell part | GO:0005829; cytosol | 3.785E-02 | 1.000E+00 | GMNN, MAPKAPK2, MAPKAPK5, PRKCD |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 5.272E-04 | 7.907E-03 | MAPKAPK2, PRKCD |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 2.348E-03 | 1.761E-02 | MAPKAPK2, MAPKAPK5 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04930 | Type II diabetes mellitus | 1.432E-02 | 4.399E-02 | PRKCD |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04370 | VEGF signaling pathway | 1.816E-02 | 4.399E-02 | MAPKAPK2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04912 | GnRH signaling pathway | 2.699E-02 | 4.399E-02 | PRKCD |
09150 Organismal Systems | 09157 Sensory system | hsa04750 | Inflammatory mediator regulation of TRP channels | 2.905E-02 | 4.399E-02 | PRKCD |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.992E-02 | 4.399E-02 | PRKCD |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.111E-02 | 4.399E-02 | NR1H4 |
09150 Organismal Systems | 09151 Immune system | hsa04666 | Fc gamma R-mediated phagocytosis | 2.758E-02 | 4.399E-02 | PRKCD |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 3.226E-02 | 4.399E-02 | PRKCD |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | NPSR1; |